Innovative technologies and a diverse product pipeline help de-risk product specific execution. Marizyme has focused on large markets including CABG surgery, fat grafting, pet health, and CKD. Access into any and all of these markets provide significant clinical and economic opportunity.
| Product | Indication | Research | Development | Clinical Trial | CE Marked | FDA Approval |
|---|---|---|---|---|---|---|
 |
Vascular Grafts Storage Vascular and Flushing Solution during CABG Surgery (DuraGraft is not yet available for sale in the US) |
|||||
 |
Pet Health - Dental | |||||
 |
Measurement of Urine Albumin and Creatinine (ACR) | |||||
 |
Measurement of Urine ACR and Blood-Based eGFR |